SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-19-003975
Filing Date
2019-03-27
Accepted
2019-03-27 09:53:09
Documents
1
Period of Report
2019-03-25

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2157
  Complete submission text file 0001493152-19-003975.txt   3821
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address
Raines Heather (Reporting) CIK: 0001770650 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36457 | Film No.: 19707043